chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Arthralgia; Rigors; Severe headache; Severe myalgia; Nausea; Sore throat; Fever; first dose on 18Dec2020, second dose on 07Jan2021; first dose on 18Dec2020, second dose on 07Jan2021; This is a spontaneous report from a contactable Physician reported for himself.  A 46-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 07Jan2021 09:00 in left arm at single dose for COVID-19 immunization.  Medical history included carotid dissection. Patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 18Dec2020 17:00 for COVID-19 immunization. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not have COVID tested post vaccination and did not have COVID prior vaccination. The patient had no known allergies. Concomitant medication included atorvastatin, acetylsalicylic acid (ASPIRIN). The patient experienced arthralgia, rigors, severe headache, severe myalgia, nausea, sore throat, fever all on 07Jan2021 20:00 with outcome of recovering. No treatment was received. Information about lot/batch number has been requested.
After both shots I got my period exactly 3 days later. I never really get my period because I am on the nexplannon implant for birth control. I also had all the period symptoms. Sore breasts, acne, and very bad cramps. Worse than normal.
The patient is an RN and she called me Saturday am after the vaccine. She said she thought she was having an allergic reaction. She said it was swollen and somewhat red. It itched just slightly. She also mentioned a rash on her legs. I recommended to do an ice pack and also an antihistamine for the weekend. I also asked her to mark the edges with a ball point pen to be able to monitor for it increasing in size. I told her to seek treatment if it got worse in spite of recommendations. I checked on her on 10/2/17 and she reported that the whelp was about same size  but not as pronounced. I sent her a message today to follow up but I have not received a response yet.
Patient describes pain at the injection site after receiving the shot. Then her arm turned into a golf-ball size lump that felt hard to the touch. She then describes that for a month after receiving the injection, she was having a hard time raising her arm and that it was still painful to the touch. She decided to go see her doctor after about a month and they described her as having "frozen shoulder". Two steroid shots, physical therapy, and a meloxicam prescription later, she still cannot move her arm well.
patchy hives, itchy, turned into head to toe hives with swelling. Treated with 50mg Benadryl injection and solumedrol injection. 4 hours later upon waking up symptoms had resolved. given prednisone pack to treat as well and oral benadryl prn for itching.
Patient reports that he has been getting a red bug bite appearing mark at injection sites, no pain or itching,  but they are hot to the touch.  Intermittent and not at the same time, resolve after a few days and then reappear.  No treatment has been tried.
Sore arm and shoulder. Pain and numbness from shoulder to hand.  Pain and numbness still occurring and worse currently as of 10/28/2013. Seen primary physician today and prescribed ibuprofen and nuerton and monitoring for another week. Shot seemed to be administered high on shoulder day of vaccine. Vaccine was given at  onsite clinic performed by another company. No previous issues or injuries to arm prior to vaccine.
received Fluzone booster injection 02/28/2020 at 750AM. IM Rt lateralis vastus. At noon mom notes red bumps posterior Neck which also involved Rt lateral abdominal, Rt thigh.
received Pfizer vaccine for the 1st dose and Moderna for the 2nd dose; This spontaneous case was reported by an other health care professional and describes the occurrence of INTERCHANGE OF VACCINE PRODUCTS (received Pfizer vaccine for the 1st dose and Moderna for the 2nd dose) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017C21A) for COVID-19 vaccination.    Co-suspect product included non-company product TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) for COVID-19 vaccination.    No Medical History information was reported.   On 05-Apr-2021, the patient received first dose of TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) (unknown route) 1 dosage form. On 30-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced INTERCHANGE OF VACCINE PRODUCTS (received Pfizer vaccine for the 1st dose and Moderna for the 2nd dose). On 30-Apr-2021, INTERCHANGE OF VACCINE PRODUCTS (received Pfizer vaccine for the 1st dose and Moderna for the 2nd dose) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Action taken with mRNA-1273 in response to the events was not applicable. No concomitant medications information was reported. No treatment medications were provided.  For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Accidental 2nd dose given (first dose 9/20, second 9/27)
weakness; out of it and tired; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (weakness) and FATIGUE (out of it and tired) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination.     The patient's past medical history included COVID-19.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Feb-2021, the patient experienced ASTHENIA (weakness) and FATIGUE (out of it and tired). On 27-Feb-2021, ASTHENIA (weakness) and FATIGUE (out of it and tired) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter. No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 28-Jul-2021: TCR follow-up received included no new information.
This spontaneous report was received from register nurse referring to a patient of unknown age. The patient's pertinent medical history, concurrent conditions, drug reactions/allergies and concomitant medications were not provided. On 06-FEB-2019, the patient was vaccinated with M-M-R II lot # R013129 Expiration date 03-FEB-2019 (strength, dosage, frequency were not reported) for prophylaxis. No adverse event was reported.
Vomiting, diarrhea, fever, chills/shaking, and loss of energy on Nov 23.  Diarrhea and low energy on the 24th and 25th.
Patient received expired vaccine. Vaccine expired on 4/4 in the freezer but wasn?t noticed and sent to clinic who administered expired vaccine to patient on 4/6
Received fist dose of Pfizer's and second of Moderna's; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of INTERCHANGE OF VACCINE PRODUCTS (Received fist dose of Pfizer's and second of Moderna's) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INTERCHANGE OF VACCINE PRODUCTS (Received fist dose of Pfizer's and second of Moderna's). At the time of the report, INTERCHANGE OF VACCINE PRODUCTS (Received fist dose of Pfizer's and second of Moderna's) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   concomitant medicines was not reported by reporter   treatment information was not provided  patient had taken  first dose of Pfizer vaccine and second dose of Moderna vaccine patient is planning to take 2nd shot of Moderna vaccine on 11 may 2021
Tdap Vaccine administered first and HPV vaccine second. As soon as patient was injected with the HPV he reported feeling lightheaded, faint, very shaky (hands and legs were shaking), and felt like he was going to throw up. Patient did look pale. Patient transferred to bed from chair with MA's help, laid down on bed. Was given a emesis bag in case, ice packs given to patient and placed on forehead and injection site. Cup of water given per patient request. Provider informed, provider spoke to patient. Patient waited in room for 15 minutes, he reports feeling better. Blood Pressure was rechecked, it was 80/50, patient asked to wait again for 15 minutes. Blood Pressure repeated after 15 min and it was 100/78, back to normal for patient. Patient Discharged. Per Provider, HPV vaccines will be hold off for now for patient.
A report had been received from a health professional that concerned a 04 year old male patient. Concomitant medication included salbutamol sulfate. The patient did not have a history of asthma. The patient did not have history of allergies and lung disease. The medical history and the concomitant medications were not reported. The patient received nasal FLUMIST QUADRIVALENT (Intranasal) on an 03-Oct-2012 and then on 05-Oct-2013 for unknown indication. The patient who received FLUMIST QUADRIVALENT had not wheezed in the past two years, but wheezed after FLUMIST QUADRIVALENT on 18-Oct-2013 and almost had to go to the emergency room. The patient also became very sick with flu like symptoms within 24 hours. He has received FLUMIST in the past without any adverse events. The lot number: BH2186 Exp date: 09-Dec-2013. On unspecified date, the patient experienced coughing. The outcome of the events of wheezing, flu-like symptoms and coughing was unknown. The reporter considered the events of wheezing, coughing and flu-like symptoms to be non-serious. Summary of follow up information received by MedImmune on 23-Oct-2013 and 06-Nov-2013 from Responsible Physician: New non serious event coughing added. Concomitant drug added. Dosing regimen of suspect drug added. The start date of the event wheezing added. Patient details added. Corrected report 12-Nov-2013: The reporter type of other changed of responsible physician and the earlier reporter type as responsible physician deleted. Vaccinated at and vaccine purchased with added.
2 pts recvd 3 doses of Engerix-B & it was determined that both pts were non-responders; Outcome: not protected; pt recvd booster dose; Post vax titer revealed HBSAB weakly reactive;
1st and 2nd dose given 16 days apart; A spontaneous report was received from a pharmacist concerning a male of unknown age, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced "1st and 2nd dose given 16 days apart".  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 13 Jan 2021, the patient received their first of two planned doses of mRNA-1273 (Lot number: 013L20A) intramuscularly for prophylaxis of COVID-19 infection. On 29 Jan 2021, the patient received their second of two planned doses of mRNA-1273 (Lot number: 007M20A) intramuscularly for prophylaxis of COVID-19 infection  It was reported that the patient was administered 1st and 2nd dose of Moderna covid-19 vaccine with in 16 days.  Action taken with mRNA-1273 in response to the events was not reported.  The outcome of the event "1st and 2nd dose given 16 days apart" was considered as resolved on 29 Jan 2021.; Reporter's Comments: This case concerns a male patient of unknown age who received his two planned doses of mRNA-1273 (Lot number: 013L20A and Lot number: 007M20A) within 16 days apart. There were no reported adverse events after the vaccines were administered in this case of inappropriate schedule of product administration
A report was received from a health care professional on 10/24/03 concerning 4 vaccinees of unspecified demography who experienced redness and wheals at the injection site with itching on the same day as receiving Fluvirin on 10/24/03. On 10/24/03 the vaccinees experienced redness and wheals at the injection site with itching. The vaccinees recovered on 10/24/03. There was insufficient information to determine the reporter's causality assessment. Follow up pending. Update 11/17/03: A follow up report was received indicating that a 34 year old female vaccinee experienced a local red wheal with redness, swelling, hives, and warmth within 20 minutes of receiving Fluvirin on 10/15/03. The vaccinee was treated with antihistamines. The vaccinee recovered after 3-5 days.
Information has been received from a nurse practitioner, for GARDASIL, a Pregnancy Registry product, concerning a 17 year old female who on 03-JUL-2008 was vaccinated with the first dose of GARDASIL.  The patient has only been given the first dose of GARDASIL.  The patient was 5 weeks pregnant but has already started the GARDASIL vaccine series.  The patient had an abnormal PAP smear when she reported being pregnant but she already started the GARDASIL series.  The patient sought medical attention.  Additional information has been requested. Follow up information has been received from a nurse practitioner concerning a 17 year old female who was 36 weeks intrauterine pregnancy. The patient's LMP was 28-MAY-2008 and estimated delivery date was 05-MAR-2009. The patient had twice routine ultrasound on 06-OCT-2008 and 01-DEC-2008 respectively and the results were within normal limits. Additional information has been requested.
Death at Hospital 02/23/2022.  Cardiogenic shock Myocardial Infarction
Seven days later became very cranky and developed a fixed erythematous nodular/papular rash.  Strep throat cx (-)/observed and resolved over >= 1 week.
not steady on his feet; diarrhea; stumbles; Felt bad; nausea; slight headache; difficulty focusing after turning head; Weird eyesight; This case was reported by a consumer via call center representative and described the occurrence of nausea in a 82-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   In June 2019, the patient received the 2nd dose of Shingrix (intramuscular). In June 2019, immediately after receiving Shingrix, the patient experienced nausea, headache, difficulty focusing eyes and abnormal vision. On 15th July 2019, the patient experienced feeling bad. On an unknown date, the patient experienced unsteadiness, diarrhea and walking difficulty. On an unknown date, the outcome of the nausea, headache, difficulty focusing eyes, unsteadiness, diarrhea, walking difficulty and feeling bad were not recovered/not resolved and the outcome of the abnormal vision was unknown.   It was unknown if the reporter considered the nausea, headache, difficulty focusing eyes, abnormal vision, unsteadiness, diarrhea, walking difficulty and feeling bad to be related to Shingrix.  Additional details were provided as follows: The patient received dose of Shingrix in the left arm. Less than a year after vaccination, the patient experienced unsteadiness, diarrhea and walking difficulty. The patient went to his physicain for stool sample and had ultrasound. The stool analysis and ultrasound came back normal. On 15th July 2019, the patient felt bad, so he went to the emergency room and did CT scan with blood check, but could not found anything wrong. The patient claimed that, his side effects were worsening. The patient consented to follow up. There was the discrepancy between the outcome reported in the structured field (not recovered) and the outcome reported in the source document (recovering).      Lab Comments: On an unknown date, stool analysis, ultrasound, CT scan and blood test were performed.
Chills, body ache head to toe, sensitive and achy skin, tingly feeling on arms, bottom of feet, fatigue, headache. Had the same symptoms after the first shot and they lasted 48 hours before I started feeling better.
One week after the injection my arm swelled at the injection site, became red, had a brittle rash and itched like a son-of-a-gun.  There was no pain really.  The area was about 5-7" long and 3-4" wide.  It resolved in about 4 days.
Headache after the first dose of COVID-19 Vaccine; Fatigue and tiredness after the first dose of COVID-19 Vaccine; This is a spontaneous report from a contactable consumer. A 52-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL942 or EL0142 hard to read writing on patient card provided) at left arm, via an unspecified route of administration on 29Dec2020 16:30 at single dose for covid-19 immunisation. Medical history was none. Concomitant medication included ongoing biotin, ongoing fish oil, ongoing vitamin D3, ongoing cyanocobalamin (VITAMIN B12) and Multivitamin. The patient experienced headache after the first dose of covid-19 vaccine on 29Dec2020, fatigue and tiredness after the first dose of covid-19 vaccine in Dec2020. Patient stated she had the first dose of the vaccine on 29Dec2020 and had the normal side effects headache, fatigue, and general tiredness. The headache lingered for two days or so and that was longer than anyone else she knows who experience a headache after getting the COVID-19 Vaccine. On the night of 29Dec2020 she started to get a headache and it lasted all day the following day. She took Ibuprofen and it helped the headache subside. However, after the Ibuprofen wore off the headache would come back. The following day she had a low grade headache. After two days the headache was gone. By that point she was just left with fatigue and tiredness. She noticed the fatigue and tiredness the following two days after getting the first dose of the vaccine. She was fine by that weekend. The outcome of events was recovered.   Information on the batch/lot number has been requested.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021087124 same reporter/patient, different vaccine dose and event.
presented with palapatations, anxiexty, and nerveness,  prescribed beta blockers and lexapro sent home came back got blood work and thyroid tsh was low, t3, t4, and ft4 was all normal found nodule via ultrasound uptake and scan came back normal found my trab levels were 5.07 dignosed with graves disease
Muscle ache; fatigue; This is a spontaneous report from a contactable consumer. A 68-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Formulation: Solution for injection, Lot number: 9N6201; Expiration Date: not reported), via an unspecified route of administration, in Arm Left on 16Feb2021 10:45 as SINGLE DOSE for COVID-19 immunization. The patient medical history included Nonfatty liver disease, sleep apnoea syndrome known allergies: Penicillin and sulfa. The patient's concomitant medications were not reported. The patient experienced muscle ache, fatigue on 16Feb2021 21:00. No treatment received was received for events. The outcome of the event was recovered with sequelae.   No follow-up attempts possible. No further information expected.
Patient came to pharmacy complaining that arm soreness has lasted 3 weeks after receiving her flu vaccine.
A non-serious spontaneous report of administration of expired FLUMIST and sore throat has been received from a physician concerning a nine-year-old patient, subsequent by FLUMIST. Neither relevant medical history nor concomitant medications have been reported for this patient. The patient received expired FLUMIST on 29-Dec-2011, which expired on 11-Dec-2011. On 29-Dec-2011, the patient received expired dose of FLUMIST. The patient experienced sore throat. The outcome of administration of expired FLUMIST was resolved and sore throat was unknown.
Headache, fever of 100.5, Blisters at site, blurred vision, nausea, malaise.
Hives, all over, coming & going throughout the day. Itchiness - woken up in middle of night. Appx. 10 days
Information has been received from a physician concerning a 60-day-old male twin who on 26-DEC-2006 was vaccinated PO with the first 2.0 ml dose of Rotateq (Lot # 655483/1116F). Concomitant vaccinations on that same day included a dose of Prevnar (Lot #B08655A) and the first IM dose of PedvaxHib (Lot #6543399/0785F). There was no illness at the time of developed a rash on his trunk, face and legs. Unspecified medical attention was sought. No laboratory/diagnostic tests were performed. A diagnosis of viral exanthema was made. The physician reported that on 26-DEC-2006, the patient developed a rash on his trunk, face and legs. Unspecified medical attention was sought. On 29-DEC-2006, the patient's rash resolved. The physician noted that the patient would receive additional doses of Rotateq. Additional information is not expected. On morning of 28-DEC-2006 (previously reported as 26-DEC-2006), the patient developed a rash on his trunk, face and legs. On 29-DEC-2006 (previously reported as 27-DEC-2006), the patient viral exanthema resolved. Additional inforamtion is not expected.
Flu like symptoms, fatigue, nausea, vomiting, vertigo, headaches.
she had a lump at injection site; This case was reported by a pharmacist via call center representative and described the occurrence of injection site lump in a 70-year-old female patient who received Herpes zoster (Shingrix) (batch number EG55L, expiry date 7th December 2021) for prophylaxis.   On 11th November 2019, the patient received the 1st dose of Shingrix. On an unknown date, less than a week after receiving Shingrix, the patient experienced injection site lump. On an unknown date, the outcome of the injection site lump was not recovered/not resolved.   It was unknown if the reporter considered the injection site lump to be related to Shingrix.  Additional details were provided as follows: The patient received Shingrix and had lump at the injection site within a week that was still unresolved. The reporter consented to follow up for additional details.
Nausea, Headaches,  Dizziness, Mild Pain. Flu-like symptoms.  Started a few hours after vaccine. Stronger symptoms  lasted 2-3 days.  Lingering, less intense symptoms lasted 4-5 days. Didn?t feel fully better till 6th day. Treatment: Ibuprofen.
Patient experienced loss of balance and inability to stand up. Body became rigid while lying on floor with tremors in extremities.
Systemic: Fainting / Unresponsive-Severe, Systemic: Nausea-Severe, Additional Details: Patient felt light headness, gave patient water, he ate sour patch kids then he said hes ok but will sit for 30 minutes, but he lost consciouness for about 20 seconds, woke up then started vomitting, we called 911 and Paramedic came took his vital signs bp 117/91 seems ok but patient refuse to go to emergency room, patient stayed for another 30 mins, his family came and picked him up. Patient said he will call his PCP if still nausea problem, patient said he fainted with injections before but never violently vomt
No adverse effects were reported; inadvertently administered one dose of expired PNEUMOVAX23; This spontaneous report was received from a medical assistant referring to a patient of unknown age and gender. There was no information about the patient's concurrent conditions, drug reactions, allergies, medical history, and concomitant therapies provided.  On 13-NOV-2019, the patient was inadvertently administered one dose of expired pneumococcal vaccine, polyvalent (23-valent)(PNEUMOVAX23)(strength and route were not reported)(lot # R002084, expiration date was 26-OCT-2019) for prophylaxis. No adverse effects were reported.